GLUT3 is overexpressed in various cancer cells, such as glioblastoma (43), ovarian cancer (44), gastric cancer (45, 46), and non-small cell lung cancer (46), due to its high glycolytic efficiency. This evidence concerns the gene SLC2A3 and glioblastoma.